Lisa Hirose
Overview
Explore the profile of Lisa Hirose including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iizawa M, Hirose L, Nunotani M, Nakashoji M, Tairaka A, Fernandez J
Inflamm Intest Dis
. 2023 Jul;
8(1):1-12.
PMID: 37404383
Introduction: Previous studies have reported the effectiveness of inflammatory bowel disease (IBD) self-management. However, it is unclear which types of self-management interventions are effective. We conducted a systematic literature review...
2.
Kobayashi T, Udagawa E, Hirose L, Hibi T
Intest Res
. 2022 Dec;
21(2):205-215.
PMID: 36516820
Background/aims: Risks of long-term steroid use in patients with ulcerative colitis (UC) outweigh the benefits, thus dosing should be tapered once a response is achieved. Colonoscopy is a key technique...
3.
Okazaki Y, Murray J, Ehsani A, Clark J, Whitson R, Hirose L, et al.
Biol Res
. 2022 Feb;
55(1):6.
PMID: 35115057
No abstract available.
4.
Okazaki Y, Murray J, Ehsani A, Clark J, Whitson R, Hirose L, et al.
Biol Res
. 2020 Oct;
53(1):45.
PMID: 33023658
Background: Skeletal muscle has an important role in regulating whole-body energy homeostasis, and energy production depends on the efficient function of mitochondria. We demonstrated previously that AT-rich interactive domain 5b...
5.
Hirose L, Hiramoto T, Tian Y, Kohara H, Kobayashi S, Nagai E, et al.
J Med Primatol
. 2020 Jan;
49(2):86-94.
PMID: 31930552
Background: For the diagnosis and treatment of adult T-cell leukemia/lymphoma (ATLL) caused by human T-lymphotropic virus type 1 (HTLV-1) are required therapeutic modalities urgently. Non-human primate models for ATLL would...
6.
Jia Y, Miyamoto S, Soda Y, Takishima Y, Sagara M, Liao J, et al.
Mol Ther Oncolytics
. 2019 Mar;
12:246-258.
PMID: 30891489
Oncolytic virotherapies have emerged as new modalities for cancer treatment. We previously reported that coxsackievirus B3 (CVB3) is a novel oncolytic virus (OV) with a strong ability to lyse human...
7.
Kohara H, Utsugisawa T, Sakamoto C, Hirose L, Ogawa Y, Ogura H, et al.
Exp Hematol
. 2019 Mar;
73:25-37.e8.
PMID: 30876823
Krüppel-like factor 1 (KLF1), a transcription factor controlling definitive erythropoiesis, is involved in sequential control of terminal cell division and enucleation via fine regulation of key cell cycle regulator gene...
8.
Iwata M, Hirose L, Kohara H, Liao J, Sawada R, Akiyoshi S, et al.
J Med Chem
. 2018 Oct;
61(21):9583-9595.
PMID: 30371064
Developing drugs with anticancer activity and low toxic side-effects at low costs is a challenging issue for cancer chemotherapy. In this work, we propose to use molecular pathways as the...
9.
Hirose L, Nosaka K, Newton M, Laveder A, Kano M, Peake J, et al.
Exerc Immunol Rev
. 2005 Jan;
10:75-90.
PMID: 15633588
The aims of this study were to examine the plasma concentrations of inflammatory mediators including cytokines induced by a single bout of eccentric exercise and again 4 weeks later by...